Lifestyle Medicine and Epilepsy in Viet Nam: Sleep Regularity, Seizure Safety, and Treatment Adherence

Lifestyle Medicine and Epilepsy in Viet Nam: Sleep Regularity, Seizure Safety, and Treatment Adherence

Primary category: Evidence & Clinical Practice

Secondary category: Lifestyle Medicine in Viet Nam

Article type: VLMA Perspective

Last reviewed: October 31, 2026

A university student living with epilepsy may stay awake late preparing for an examination and worry about having a seizure the following day. Another person may take prescribed medication regularly but continue to experience seizures that disrupt work and family life. Someone else may avoid swimming, exercise, or social activities because family members fear that physical exertion could trigger a seizure.

These situations illustrate how epilepsy affects more than seizure frequency. It can influence sleep, daily routines, treatment decisions, personal safety, confidence, and participation in society.

Lifestyle-related factors can be relevant, but their effects vary considerably. Sleep deprivation may increase seizure susceptibility in some people, while others experience seizures despite adequate sleep and appropriate health behaviors. Physical activity can support general health, but certain activities require additional safety precautions. Difficulties taking medication may reflect practical barriers, adverse effects, or concerns about treatment rather than a lack of motivation.

Evidence-based Lifestyle Medicine can contribute by supporting appropriate sleep habits, physical activity, medication-taking routines, and sustainable self-management. These measures must remain part of comprehensive neurological care, however, and cannot replace antiseizure medication or other indicated treatments.

For healthcare professionals in Viet Nam, an important challenge is to identify factors that can reasonably be addressed without attributing every seizure to personal behavior. Patients also need support to maintain appropriate treatment, understand relevant risks, and participate in everyday activities without unnecessary restrictions.

Understanding Epilepsy Beyond Convulsive Seizures

Epilepsy is a neurological disease characterized by an enduring predisposition to generate epileptic seizures. These seizures arise from abnormal excessive or synchronous electrical activity in the brain and can produce a wide range of clinical manifestations.

Some seizures involve prominent muscle stiffening and rhythmic jerking. Others may cause brief interruptions in responsiveness, unusual sensations, involuntary movements, changes in behavior, or disturbances in perception. Not every epileptic seizure involves falling to the ground or losing consciousness.

A single seizure also does not automatically establish a diagnosis of epilepsy. Some seizures occur in association with acute medical problems or other provoking circumstances, while events that resemble epileptic seizures may have different causes.

The International League Against Epilepsy's operational definition recognizes epilepsy when a person has experienced at least two unprovoked or reflex seizures more than 24 hours apart, one unprovoked or reflex seizure with a sufficiently high probability of recurrence, or a recognized epilepsy syndrome. For the second criterion, the estimated recurrence probability is at least 60% over the following 10 years. [1]

Appropriate clinical evaluation may include a detailed history, eyewitness descriptions, electroencephalography, brain imaging when indicated, and investigation of possible underlying causes. Clinicians must also consider conditions that can resemble epileptic seizures, including syncope, metabolic disturbances, certain sleep disorders, and functional nonepileptic seizures.

In April 2025, the International League Against Epilepsy published an updated classification of epileptic seizures. The revision retains four main classes: focal, generalized, unknown whether focal or generalized, and unclassified seizures. It also identifies 21 seizure types and provides a clearer distinction between classification criteria and descriptive features. [2]

An important change is the use of consciousness instead of awareness as a classifier in relevant seizure categories. Consciousness is operationally assessed through both awareness and responsiveness. The updated classification also replaces the previous motor versus nonmotor distinction with descriptions based on observable and nonobservable manifestations.

These changes support more consistent clinical communication and seizure identification. They do not, however, constitute recommendations for lifestyle interventions.

For patients and families, the practical point is that accurate seizure classification matters. Treatment and safety advice should not be based solely on whether an episode resembles a conventional convulsion.

Antiseizure Treatment Remains Central to Epilepsy Care

Antiseizure medications are a cornerstone of epilepsy management.

The World Health Organization estimates that up to 70% of people living with epilepsy could become seizure-free with appropriate diagnosis and treatment. This is a population-level estimate of what effective care may achieve, not a prediction for an individual patient. [4]

Treatment response varies according to seizure type, epilepsy syndrome, underlying cause, medication selection, associated medical conditions, and individual circumstances.

The National Institute for Health and Care Excellence guideline NG217, last updated on January 30, 2025, emphasizes individualized treatment selection based on these factors. Medication choice may also be influenced by potential adverse effects, interactions, reproductive considerations, and patient preferences. [3]

Antiseizure medicines are therefore not interchangeable. A medication effective for one seizure type may be unsuitable for another, and some medicines can worsen particular seizure types.

Patients should not independently stop, reduce, or change prescribed medication because they have remained seizure-free or adopted healthier habits.

Medication withdrawal may be considered in selected circumstances after an individualized assessment. NICE recommends evaluating recurrence risk after two years of seizure freedom rather than automatically discontinuing treatment at that point. The assessment should consider epilepsy type, previous treatment response, the possible consequences of recurrence, and the person's circumstances, including employment and driving. [3]

Some patients continue to experience seizures despite appropriate treatment.

The International League Against Epilepsy defines drug-resistant epilepsy through failure of adequate trials of two appropriately selected and tolerated antiseizure medication regimens to achieve sustained seizure freedom. [5]

When this occurs, specialist reassessment is important. The diagnosis, seizure classification, medication history, treatment adherence, and possible contributing factors may need review.

Depending on the findings, additional treatment options may include epilepsy surgery, neuromodulation, or professionally supervised dietary therapy.

Lifestyle counseling must not delay these assessments or be presented as an alternative to specialist treatment for persistent seizures.

Sleep Regularity Matters, but the Relationship Is Complex

Sleep and epilepsy have a bidirectional relationship. Sleep deprivation may increase seizure susceptibility in some people, while seizures themselves can disrupt sleep and contribute to daytime fatigue.

Certain epilepsy syndromes are particularly associated with sleep or transitions between sleeping and waking. However, the relationship is not uniform.

One person may notice a repeated association between substantial sleep loss and seizures. Another may experience seizures despite regularly obtaining adequate sleep. In some situations, apparent associations may be influenced by illness, medication changes, stress, or other factors occurring at the same time.

Research and clinical experience support sleep deprivation as a relevant seizure-provoking factor in susceptible individuals. Nevertheless, determining whether a particular seizure was directly caused by a modest variation in sleep can be difficult.

Information published by the Epilepsy Society and updated in September 2026 similarly recognizes that insufficient sleep may increase seizure likelihood for some people, while nocturnal seizures and sleep disorders may contribute to disrupted sleep. [8]

Healthcare professionals should avoid suggesting that patients are personally responsible for seizures because they did not sleep properly. Such explanations can create unnecessary guilt and overlook underlying neurological disease, inadequate seizure control, or other medical concerns.

Maintaining a reasonably consistent sleep schedule and obtaining adequate sleep are sensible supportive measures. However, no particular bedtime or sleep duration guarantees seizure control.

Patients who notice repeated associations between sleep loss and seizures may benefit from reviewing their routines, occupational demands, medication timing, and other possible contributors with their treating clinician.

For people working rotating shifts or overnight schedules, achieving consistent sleep can be difficult. This may be relevant to workers in manufacturing, healthcare, hospitality, transportation, and other occupations involving irregular hours in Viet Nam.

Recommendations should account for these circumstances rather than assume that everyone can freely control their working schedule.

When Poor Sleep Needs Medical Assessment

Poor sleep in someone with epilepsy should not automatically be attributed to unhealthy habits.

Insomnia, obstructive sleep apnea, restless legs symptoms, medication effects, and nocturnal seizures may contribute to disturbed sleep or daytime fatigue.

A person who snores loudly, experiences witnessed breathing pauses, and reports excessive daytime sleepiness may require assessment for obstructive sleep apnea. Another who experiences unusual repetitive movements or episodes of confusion during sleep may need investigation to distinguish nocturnal seizures from other sleep-related events.

These distinctions can be difficult and may require specialist evaluation.

Certain antiseizure medicines may contribute to sleepiness, insomnia, or changes in sleep patterns. Patients should not independently change medication timing or discontinue treatment to improve sleep.

When a separate sleep disorder is identified, appropriate treatment may improve sleep quality and daytime functioning. Whether seizure control also improves depends on the individual and the condition being treated.

Treating insomnia or sleep apnea should not be presented as a way to eliminate epilepsy or withdraw antiseizure medication.

The appropriate role of Lifestyle Medicine is to support healthy sleep behaviors while recognizing when additional clinical assessment is necessary.

Seizure Triggers: Understanding Patterns Without Assuming Causation

People living with epilepsy often want to understand what makes their seizures more likely.

Common questions concern stress, insufficient sleep, flashing lights, certain foods, alcohol, exercise, or changes in daily routines.

Some individuals have identifiable seizure-provoking factors, while others experience seizures without an obvious external trigger.

Photosensitivity, for example, occurs in certain epilepsy syndromes but should not be assumed in everyone with epilepsy. Exposure to electronic screens does not automatically mean that someone is at risk of photosensitive seizures.

Stress and fatigue are frequently reported around seizure events, but their relationship with seizure occurrence may be difficult to separate from changes in sleep, illness, medication-taking, and underlying seizure susceptibility.

Alcohol also deserves consideration. Heavy alcohol consumption and alcohol withdrawal can increase seizure risk. Smaller amounts may have more variable effects, while alcohol can interact with antiseizure medication and affect sleep or judgment.

People with alcohol dependence may face additional risks from abrupt withdrawal and should receive appropriate medical assessment rather than attempting potentially hazardous unsupervised withdrawal.

Avoiding harmful alcohol use is relevant to general health and may be particularly important in epilepsy care. Nevertheless, clinicians should be cautious about attributing an individual seizure to a particular exposure without adequate evidence.

A seizure diary can help patients and clinicians identify patterns over time. Useful information may include when an event occurred, its characteristics, duration, recovery afterward, medication-taking, sleep changes, illness, and other notable circumstances.

Eyewitness descriptions can be especially valuable when the patient cannot fully recall what happened.

However, a diary cannot independently prove that a particular exposure caused a seizure. Patterns may arise by chance, and several factors can occur together.

Patients should not be encouraged to adopt restrictive diets, avoid ordinary activities, or make major lifestyle changes solely because a small number of seizures appeared to coincide with a particular circumstance.

The purpose of reviewing possible triggers is to identify clinically relevant patterns and opportunities for safer management, not to assign responsibility for seizure occurrence.

Physical Activity Should Be Supported, Not Automatically Restricted

Many people with epilepsy can participate safely in appropriate physical activity. However, concerns about seizure-related injuries sometimes lead patients or families to restrict exercise unnecessarily.

These concerns are understandable, particularly when seizures involve impaired consciousness, falls, or loss of motor control.

Avoiding physical activity altogether can also have consequences. Inactivity may contribute to reduced cardiovascular fitness, loss of muscle strength, weight gain, poorer mental well-being, and reduced social participation.

The International League Against Epilepsy Task Force on Sports and Epilepsy published recommendations in 2016 encouraging individualized assessment rather than automatic exclusion from sporting activities. [7]

The guidance considers seizure characteristics, likelihood of recurrence, treatment response, the risks associated with a particular activity, and what could happen if a seizure occurred during participation.

Walking, selected forms of strength training, and many recreational activities may be appropriate for individuals whose clinical circumstances allow safe participation.

Other activities require more careful assessment.

Swimming, water sports, climbing, cycling in traffic, activities at height, and activities involving moving machinery can have serious consequences if a seizure occurs.

Water-related activities deserve particular caution because a seizure in water can rapidly become life-threatening. Decisions about swimming and other water activities should consider seizure control, the environment, appropriate supervision, and the availability of someone capable of responding to an emergency. Uncontrolled seizures may make certain water activities unsafe.

The precautions needed by someone with ongoing seizures affecting consciousness may differ substantially from those required by a person who has remained seizure-free for a prolonged period.

The aim is to support participation wherever risks can be reasonably managed rather than impose broad restrictions solely because of the diagnosis.

Exercise should not be promoted as a proven replacement for antiseizure medication or as a universally effective method of reducing seizure frequency.

Its benefits for physical health, functioning, and well-being remain important even when its direct effects on seizure control are uncertain.

Seizure First Aid Is an Important Part of Safety Education

Seizure safety involves more than avoiding potentially dangerous activities. Patients, family members, teachers, caregivers, and relevant workplace colleagues may benefit from understanding how to respond when a seizure occurs.

The 2024 American Heart Association and American Red Cross first aid guidelines provide evidence-informed recommendations for seizure management by first aid providers. [6]

During a convulsive seizure, bystanders should protect the person from injury, clear nearby hazards when possible, and remain with them. The person should not be physically restrained.

Nothing should be forced into the mouth. Food, liquids, and oral medicines should not be given during a seizure or while the person remains insufficiently responsive afterward.

A person cannot swallow their tongue during a seizure. Attempting to hold the mouth open or insert objects can cause injuries to both the patient and the person providing assistance.

When safe and feasible, the person should be placed on their side in a recovery position to help protect the airway. This should be done without forcibly restraining movements or creating additional injury risk. If the person is unresponsive and not breathing normally after the seizure, emergency resuscitation measures may be necessary according to the responder's training and emergency dispatcher instructions.

The duration of the seizure should be noted.

A convulsive seizure reaching approximately five minutes requires emergency action because prolonged convulsive activity may represent status epilepticus. Emergency assistance is also important for repeated seizures without recovery, a first recognized seizure, a seizure occurring in water, significant injury, breathing difficulty, or failure to return to the usual level of responsiveness.

Seizures during pregnancy and seizures in infants younger than six months also warrant particular urgency.

In Viet Nam, the medical emergency number is 115.

Some patients have individualized seizure action plans that include prescribed rescue medication. Appropriately trained caregivers should follow those plans and the treating team's instructions.

General first aid information cannot replace patient-specific emergency guidance.

For healthcare organizations, an important educational priority is ensuring that patients and caregivers understand safe first aid, recognize situations requiring emergency assistance, and avoid harmful practices based on common misconceptions.

Sudden Unexpected Death in Epilepsy: Communicating Risk Responsibly

Sudden unexpected death in epilepsy is an important but sensitive concern.

It refers to sudden, unexpected death in a person with epilepsy that remains unexplained after appropriate investigation and is not caused by trauma, drowning, or documented status epilepticus.

The risk varies considerably between individuals.

Generalized tonic–clonic seizures, particularly when they remain uncontrolled, are an important established risk factor. Nocturnal seizures and other circumstances may also be relevant.

The NICE guideline recommends discussing epilepsy-related mortality risks in an individualized and sensitive manner. [3]

These conversations should not be avoided simply because the subject is uncomfortable, but they should also not create disproportionate fear.

Risk reduction focuses primarily on effective seizure management, appropriate medication use, and timely specialist assessment when seizures remain uncontrolled.

For selected patients, nocturnal supervision or seizure-monitoring arrangements may be considered as part of individualized care.

However, commercially available seizure-detection devices have limitations. They may fail to detect certain seizures, generate false alarms, or provide little practical benefit when no one is available to respond.

Evidence is insufficient to claim that such devices reliably prevent sudden unexpected death in epilepsy.

Patients and families should receive balanced information about possible benefits, limitations, and residual risks. The purpose is to support informed decisions and reasonable precautions without unnecessarily restricting ordinary life.

Medication Adherence Is More Than Remembering a Dose

Consistent use of prescribed antiseizure medication is important for many people with epilepsy. Yet difficulties taking medication can arise for several reasons.

Some patients forget doses because of demanding schedules or changing work shifts. Others experience adverse effects, have concerns about long-term treatment, or find complex regimens difficult to follow.

Financial pressures, medication availability, transportation difficulties, misunderstanding of instructions, and fear of stigma may also affect treatment continuity.

A person who has remained seizure-free for several months may believe medication is no longer necessary. Another may deliberately reduce treatment because of dizziness, fatigue, cognitive symptoms, or concerns about pregnancy.

These situations require different responses.

Healthcare professionals should explore medication-taking in a respectful, nonjudgmental manner. Patients need to feel able to discuss missed doses, adverse effects, and practical difficulties without fearing criticism.

A reminder may help someone who occasionally forgets medication. It will not resolve a significant adverse drug reaction or the inability to afford prescribed treatment.

Some patients may benefit from a clinically appropriate simplification of their regimen. Others need clearer information about expected benefits, review of treatment tolerability, or assistance arranging continued access to medicines.

Digital reminders and pill organizers can be useful for selected patients, but their effectiveness depends on whether they address the actual barrier.

Patients should also receive individualized advice about what to do after a missed dose. They should not assume that taking a double dose is appropriate.

The most useful approach begins by understanding why the prescribed treatment plan is difficult to follow.

What Does the 2026 Vietnamese Adherence Study Tell Us?

A study published in the Vietnamese Journal of Neurology on August 4, 2026, examined antiseizure medication adherence among 310 outpatients with epilepsy at Tam Anh General Hospital in Ha Noi. [9]

The cross-sectional study was conducted between January and April 2026. Medication adherence was evaluated using the eight-item Morisky Medication Adherence Scale.

The researchers reported that 15.5% of participants had high adherence, 47.1% had moderate adherence, and 37.4% had low adherence.

The mean age was 31.26 years. Around 33.5% were identified as having drug-resistant epilepsy, while 83.9% were receiving multiple antiseizure medicines. Sixty percent were classified as having good seizure control.

These characteristics matter when interpreting the findings. The study included a substantial proportion of patients receiving complex treatment and should not be assumed to represent all people living with epilepsy in Viet Nam.

In adjusted statistical analysis, adequate epilepsy knowledge was associated with higher odds of medication adherence, with an adjusted odds ratio of 12.04.

Good seizure control was also associated with greater odds of adherence, with an adjusted odds ratio of 4.29.

Both associations were statistically significant, but they require careful interpretation.

The study involved selected outpatients at a single hospital and relied on a self-reported adherence instrument. Such tools can provide useful information but may not capture every missed dose or accurately reflect actual medication exposure.

More importantly, the cross-sectional design cannot establish the direction of causation.

Better adherence may contribute to seizure control, but seizure control may also influence treatment beliefs, motivation, or reported medication-taking behavior. Other clinical and social factors may affect both.

Similarly, the association between epilepsy knowledge and adherence does not demonstrate that providing educational information alone would produce an equivalent improvement in adherence.

The adjusted odds ratios describe associations within the statistical model; they should not be interpreted as the expected benefits of an educational intervention or as direct increases in probability.

The findings nevertheless raise a practical question: are healthcare professionals adequately identifying what patients understand about epilepsy and the difficulties they experience in following treatment?

Answering that question requires more than simply asking whether medication is taken regularly.

Turning Treatment Knowledge Into Sustainable Behavior

Knowing what to do and being able to do it consistently are not the same.

A patient may understand why antiseizure medication is important yet struggle with a dosing schedule that conflicts with rotating work shifts. Another may recognize the value of regular sleep but have caregiving responsibilities or employment demands that make consistency difficult.

Education is necessary, but it should be connected to the person's circumstances.

Practical support may involve reviewing how treatment fits into daily routines, identifying situations in which doses are commonly missed, planning prescription refills, or addressing adverse effects with the treating clinician.

People who travel frequently or work irregular hours may need individualized advice about maintaining medication schedules.

Clear explanations and confirmation of understanding can also improve communication. The teach-back method, when used respectfully, allows clinicians to assess whether their instructions were clear rather than test the patient's intelligence.

Family members may offer useful support when appropriate, but adults with epilepsy should remain involved in decisions about their care to the fullest extent possible.

Treatment continuity also depends on healthcare services. Education alone cannot resolve medicine shortages, unaffordable treatment, or difficulties accessing specialist assessment.

These distinctions matter when designing educational or behavior-change interventions.

A program should not be evaluated solely by whether participants report greater knowledge. It should also examine whether practical barriers have been addressed, medication-taking has become more reliable, and relevant clinical or patient-reported outcomes have improved.

Medication and Dietary Safety Across Different Life Stages

Epilepsy management can change substantially over a person's lifetime.

For girls and women who may become pregnant, medication selection requires particular attention because some antiseizure medicines carry important risks to fetal development.

The NICE guideline incorporates regulatory safety recommendations concerning medicines such as valproate and topiramate. These recommendations reflect the United Kingdom's regulatory framework and should not be presented as identical to Vietnamese prescribing requirements. [3]

The underlying clinical concern is nevertheless relevant internationally.

Pregnancy planning, medication selection, seizure control, and fetal safety should be discussed before treatment changes become urgent whenever possible.

Patients should not independently discontinue antiseizure medication because they are planning pregnancy or have discovered that they are pregnant. Uncontrolled seizures can also create serious risks, and treatment decisions require individualized assessment.

Older adults may face different concerns, including falls, cognitive effects, medication interactions, kidney function, and other medical conditions. Children and adolescents may require age-appropriate education and coordination between healthcare professionals, families, and schools.

Dietary treatment is another area where clinical circumstances matter.

Ketogenic dietary therapy can benefit selected patients with particular epilepsy syndromes or drug-resistant epilepsy. However, a therapeutic ketogenic diet is not equivalent to ordinary healthy eating or a commercially promoted low-carbohydrate diet.

NICE recommends considering ketogenic dietary therapy in selected circumstances under the guidance of an experienced specialist team. [3]

Such treatment requires assessment of nutritional adequacy, relevant medical conditions, medication interactions, metabolic risks, and the person's capacity to maintain the regimen.

Potential complications include gastrointestinal symptoms, lipid abnormalities, kidney stones, micronutrient deficiencies, and other nutritional or metabolic problems. For children, growth and developmental requirements also need attention.

Patients should not independently begin a restrictive ketogenic diet in an attempt to control seizures or replace prescribed medication.

Claims that eliminating sugar, taking supplements, or following a particular commercial diet can cure epilepsy are not supported by adequate evidence.

Balanced nutrition remains important for general health, but its benefits should not be confused with the condition-specific effects of medically supervised ketogenic therapy.

This is an important boundary for Lifestyle Medicine education: specialized medical dietary treatment should not be presented as a routine lifestyle recommendation suitable for everyone.

Mental Health, Stigma, and Everyday Participation

Epilepsy can create difficulties that are not visible during a neurological examination.

Some people worry about having a seizure in public, disclosing their condition at work, or being misunderstood by colleagues and friends. Others withdraw from social activities because of previous experiences of embarrassment, discrimination, or fear of injury.

Anxiety and depression are important associated conditions that may require assessment and treatment.

However, emotional difficulties should not automatically be attributed to poor coping or insufficient resilience. Neurological factors, treatment effects, personal experiences, and social circumstances may all contribute.

The World Health Organization recognizes stigma and discrimination as important parts of the burden experienced by people living with epilepsy. [4]

Misconceptions can affect education, employment, relationships, and willingness to seek medical care.

Epilepsy is not contagious, and the diagnosis alone does not determine a person's intelligence, capabilities, or potential to participate in society.

In Viet Nam, healthcare professionals can help by providing accurate information, using respectful language, and discussing safety without automatically assuming that people with epilepsy cannot participate in ordinary activities.

Some patients may have strong family and workplace support. Others may face difficulties with disclosure, employment requirements, or access to continuing care.

Recommendations should reflect these individual circumstances.

Supporting independence does not mean ignoring seizure-related risks. It means recognizing genuine safety concerns while avoiding unnecessary restrictions.

Driving and Safety-Sensitive Activities in Viet Nam

Driving is one area where clinical risk and legal requirements must be considered together.

A person who experiences seizures involving impaired consciousness or motor control may face serious risks if a seizure occurs while driving.

However, legal eligibility cannot be determined simply by applying an international seizure-free interval.

In Viet Nam, Circular No. 36/2024/TT-BYT, issued by the Ministry of Health on November 16, 2024, and effective January 1, 2025, regulates health standards and medical examinations for drivers and operators of certain specialized vehicles. [12]

Its health requirements distinguish three groups of driving-license categories.

Under the neurological criteria in Appendix I, epilepsy with seizures occurring within the preceding 24 months, whether or not medication is being used, is listed as a disqualifying condition for Group 2. Epilepsy itself is listed as a disqualifying condition for Group 3.

Group 1 is subject to different criteria. However, the absence of the same epilepsy-specific exclusion in that group should not be interpreted as automatic medical clearance or permission to drive regardless of the individual's condition.

The relevant driving-license category, clinical circumstances, current legal requirements, and formal medical fitness assessment must all be considered.

Similar caution applies to safety-sensitive work involving heights, machinery, transportation, or other activities where loss of consciousness could have serious consequences.

Healthcare professionals should provide appropriate clinical advice while recognizing the distinction between medical risk assessment, employment requirements, and legally authorized licensing decisions.

International sports or driving guidance does not automatically establish legal permission to undertake an activity in Viet Nam.

Measuring Outcomes Beyond Seizure Counts and Medication Adherence

Medication adherence is important, but it is not the only measure of effective epilepsy care.

For many patients, sustained seizure control is a central clinical goal. Relevant outcomes may include seizure frequency, seizure type, seizure severity, periods of seizure freedom, emergency visits, hospitalizations, and seizure-related injuries.

However, seizure counts have limitations.

Some events may go unrecognized, particularly seizures occurring during sleep or involving subtle changes in consciousness. Patient diaries, caregiver observations, and appropriate clinical investigations can provide complementary information, but they do not replace professional assessment.

Medication review should also consider adverse effects, interactions, treatment burden, and whether specialist reassessment is necessary.

Patient-reported outcomes can help describe sleep quality, mood, cognitive concerns, confidence, and quality of life.

For one person, meaningful improvement may involve returning to education or employment. For another, it may mean participating safely in physical activity, reducing fear of seizures, or maintaining more predictable daily routines.

Validated epilepsy-specific quality-of-life instruments may support assessment when appropriately selected and administered.

Adherence information also requires careful interpretation.

A patient may take medication consistently but continue to experience seizures because the current treatment is inadequate. Another may have difficulty taking medication because of adverse effects that require clinical review.

Neither situation should be reduced to a judgment about personal discipline.

The purpose of assessment is to understand why care is or is not achieving the expected outcomes and identify appropriate next steps.

Lifestyle interventions should be evaluated according to their actual contribution to treatment continuity, safety, functioning, and quality of life.

Improvements in sleep or other behaviors should not automatically be presented as evidence of improved seizure control unless that outcome has been appropriately measured.

Making Epilepsy Self-Management Practical in Viet Nam

Epilepsy care involves more than prescribing medication during a neurological consultation.

Patients may need continuing access to medicines, follow-up appointments, education about seizure safety, and support for activities that matter to their lives.

The availability of specialist services and practical costs of treatment may vary between healthcare settings.

For people living far from major hospitals, travel and time away from work can complicate regular follow-up. Others may experience difficulties obtaining medication, managing complex dosing schedules, or knowing what to do after a breakthrough seizure.

These barriers should be identified rather than attributed automatically to poor personal motivation.

Primary care professionals, nurses, pharmacists, and other healthcare workers may contribute to education, medication reconciliation, recognition of adverse effects, and appropriate referral within their qualifications and authorized scopes of practice.

Specialist neurological assessment remains important when seizure patterns change, diagnosis is uncertain, treatment is ineffective, or advanced therapeutic options are being considered.

Digital reminders and remote follow-up may improve convenience for selected patients. However, these tools do not replace clinical reassessment when seizures change, significant adverse reactions occur, or treatment is no longer controlling the condition.

Access to technology, health literacy, communication needs, privacy, and patient preferences should influence how such tools are used.

Healthcare organizations may also examine whether patients receive understandable information, whether treatment barriers are documented, and whether missed follow-up appointments or medication-related concerns are addressed.

Such activities can support more reliable care, although their effects should be evaluated rather than assumed.

Professional and Legal Responsibilities in Viet Nam

The use of Lifestyle Medicine in epilepsy-related education requires a clear distinction between general health information and regulated clinical practice.

In Viet Nam, medical examination, diagnosis, treatment, prescribing, and related professional responsibilities are governed by the Law on Medical Examination and Treatment No. 15/2023/QH15, as amended, and applicable implementing regulations.

Consolidated Document No. 26/VBHN-VPQH, issued on February 26, 2026, provides an updated consolidated reference to the law. [10,11]

Healthcare professionals must act within their qualifications, competence, professional licenses, and legally authorized scopes of practice.

Diagnosis of epilepsy, interpretation of investigations for individualized treatment decisions, selection or withdrawal of antiseizure medication, and management of drug-resistant epilepsy require appropriately qualified and authorized professionals.

General Lifestyle Medicine education, professional membership, or international certification does not independently authorize an individual to provide regulated neurological treatment in Viet Nam.

International clinical guidance may inform professional education and clinical review, but it does not automatically replace Vietnamese requirements or establish regulatory approval for particular medicines, devices, or procedures.

Patient information also requires protection.

Epilepsy-related medical records, seizure videos, medication histories, treatment plans, and information about cognitive or psychological conditions may contain identifiable or sensitive personal data.

The Law on Personal Data Protection No. 91/2025/QH15 and Government Decree No. 356/2025/NĐ-CP, both effective January 1, 2026, establish relevant requirements concerning personal data processing and protection. [13,14]

Healthcare organizations and professional educational activities using identifiable patient information must consider applicable legal bases, confidentiality obligations, security safeguards, necessary permissions, and other relevant requirements.

These responsibilities are particularly important when seizure videos, digital monitoring devices, or remote healthcare services are involved.

Removing a patient's name does not necessarily eliminate identification risks. Other information may still allow the person to be recognized.

Implications for the Vietnam Lifestyle Medicine Alliance

Epilepsy provides a useful example of how Lifestyle Medicine can complement established neurological care while maintaining clear professional boundaries.

Sleep habits, physical activity, avoidance of harmful exposures, and sustainable treatment routines can contribute to general health and daily functioning. Their relevance depends on individual clinical circumstances, and their effects on seizure control should not be exaggerated.

For the Vietnam Lifestyle Medicine Alliance (VLMA), an appropriate contribution is to strengthen professional understanding through evidence-based education, critical appraisal of research, and scientific knowledge exchange.

Educational resources could examine the relationship between sleep and seizure susceptibility, the distinction between seizure-provoking factors and causal explanations, safe physical activity, medication-taking barriers, and interpretation of patient-reported outcomes.

The 2026 Vietnamese adherence study provides a useful example of how patient knowledge, treatment circumstances, and clinical outcomes may be associated without demonstrating that one directly causes another.

The 2025 update to the international Lifestyle Medicine Core Competencies also emphasizes the importance of applying behavioral interventions within the social and economic circumstances that influence people's ability to make and sustain health-related changes. This principle is relevant when considering medication affordability, working schedules, access to specialist care, and treatment continuity in epilepsy. [16]

Collaboration with qualified neurologists, epilepsy specialists, pharmacists, nurses, and other relevant healthcare professionals would help ensure that educational materials remain clinically accurate and appropriately connected to established care.

VLMA is a physician-led professional platform operated by Vietnam Lifestyle Medicine Alliance Company Limited. Its activities focus on evidence-based professional education, capability development, scientific knowledge exchange, and responsible collaboration.

VLMA does not independently diagnose epilepsy, prescribe or modify antiseizure medication, provide specialist neurological treatment, or manage individualized seizure emergencies.

Its contribution is to support professional understanding and the responsible interpretation of scientific evidence within authorized healthcare services.

Living Safely With Epilepsy Requires More Than Avoiding Triggers

For someone living with epilepsy, effective care may mean achieving sustained seizure control, attending work or university with greater confidence, participating safely in physical activity, or having family members who know how to respond when a seizure occurs.

These outcomes depend on more than lifestyle habits alone.

Accurate diagnosis, appropriate medication, specialist assessment when needed, and reliable treatment continuity remain central. Sleep and other daily behaviors may also matter, but their effects should be evaluated without making patients responsible for every seizure.

The 2025 International League Against Epilepsy classification provides an updated framework for describing seizure types, while NICE guidance supports individualized treatment and safety planning.

Research from Viet Nam adds locally relevant evidence about medication-taking behavior and highlights the importance of identifying practical barriers to treatment.

For healthcare professionals, the challenge is to connect established neurological care with realistic behavioral support, appropriate safety measures, and respect for the person's circumstances.

Patients need treatment they can access, information they can understand, and opportunities to participate in everyday life without unnecessary stigma or restrictions.

Effective epilepsy care is not about expecting people to prevent every seizure through perfect lifestyle habits. It is about achieving the best possible seizure control, reducing avoidable harm, maintaining appropriate treatment, and helping people live with greater safety, dignity, and independence.

Selected References

1. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE Official Report: A Practical Clinical Definition of Epilepsy. Epilepsia. 2014;55(4):475–482. DOI: 10.1111/epi.12550.

2. Beniczky S, Trinka E, Wirrell E, et al. Updated Classification of Epileptic Seizures: Position Paper of the International League Against Epilepsy. Epilepsia. 2025;66(6):1804–1823. Published online April 23, 2025. DOI: 10.1111/epi.18338.

3. National Institute for Health and Care Excellence. Epilepsies in Children, Young People and Adults. NICE Guideline NG217. Published April 27, 2022. Last updated January 30, 2025.

4. World Health Organization. Epilepsy. Fact sheet. February 7, 2024.

5. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of Drug Resistant Epilepsy: Consensus Proposal by the Ad Hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–1077. DOI: 10.1111/j.1528-1167.2009.02397.x.

6. American Heart Association and American Red Cross. 2024 American Heart Association and American Red Cross Guidelines for First Aid. 2024.

7. Capovilla G, Kaufman KR, Perucca E, Moshé SL, Arida RM. Epilepsy, Seizures, Physical Exercise, and Sports: A Report From the ILAE Task Force on Sports and Epilepsy. Epilepsia. 2016;57(1):6–12. DOI: 10.1111/epi.13261.

8. Epilepsy Society. Sleep and Epilepsy. Published February 6, 2025. Updated September 8, 2026.

9. Nguyễn Thu Hà, Nguyễn Văn Liệu, Nguyễn Công Khẩn, Vũ Thị Hinh, Trương Huệ Linh. Tuân thủ thuốc kháng động kinh và yếu tố liên quan ở người bệnh động kinh tại Bệnh viện Đa khoa Tâm Anh năm 2026. Tạp chí Thần kinh học Việt Nam. 2026;49:18–25. Published August 4, 2026. DOI: 10.62511/vjn.49.2026.095.

10. National Assembly of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15. January 9, 2023, as amended.

11. Office of the National Assembly of Viet Nam. Consolidated Document No. 26/VBHN-VPQH: Law on Medical Examination and Treatment. February 26, 2026.

12. Ministry of Health of Viet Nam. Circular No. 36/2024/TT-BYT on Health Standards and Health Examinations for Drivers and Operators of Specialized Vehicles. November 16, 2024. Effective January 1, 2025.

13. National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15. June 26, 2025. Effective January 1, 2026.

14. Government of Viet Nam. Decree No. 356/2025/NĐ-CP Detailing Selected Provisions and Implementation Measures of the Law on Personal Data Protection. December 31, 2025. Effective January 1, 2026.

15. National Institute for Health and Care Excellence. Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence. Clinical Guideline CG76. January 28, 2009.

16. Rea BL, Cheema S, Lanza S, et al. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. 2026;20(3):443–451. First published online October 28, 2025. DOI: 10.1177/15598276251379821.

Editorial and Professional Scope Note

This article presents an educational and professional perspective of the Vietnam Lifestyle Medicine Alliance (VLMA) on the potential contribution and limitations of evidence-based Lifestyle Medicine in epilepsy care. It reflects scientific and regulatory information reviewed through October 31, 2026.

The article is intended for professional information, education, and scientific knowledge exchange. It does not constitute a clinical practice guideline, individualized medical advice, an epilepsy diagnosis, a seizure-management protocol, a medication recommendation, a dietary treatment prescription, or an authoritative interpretation of Vietnamese law.

VLMA is a physician-led professional platform operated by Vietnam Lifestyle Medicine Alliance Company Limited. VLMA is not a licensed medical examination or treatment facility, specialist epilepsy service, medical licensing authority, or healthcare accreditation organization. It does not independently diagnose epilepsy, prescribe or modify antiseizure medication, perform specialized neurological investigations for individualized treatment decisions, or manage epilepsy-related emergencies.

Clinical assessment, diagnosis, treatment selection, medication adjustment or withdrawal, specialist investigation, dietary therapy, and individualized safety planning must be undertaken by appropriately qualified and legally authorized healthcare professionals and facilities within their applicable scopes of practice and in accordance with relevant Vietnamese requirements.

International classifications, clinical guidelines, and research publications are discussed for educational purposes. Their inclusion does not imply that they automatically have regulatory force in Viet Nam, establish the approval or availability of particular treatments, or indicate that VLMA has formally adopted, validated, delivered, endorsed, or certified any epilepsy management program discussed in this article.

The evidence supporting sleep-related interventions, physical activity, behavioral support, digital technologies, and specialized dietary therapies varies according to study design, patient population, epilepsy type, and measured outcomes. Findings from individual studies should not be interpreted as proof of universal effectiveness or as justification for replacing prescribed antiseizure treatment.

Lifestyle-related interventions must not delay appropriate neurological assessment, necessary treatment, specialist referral, or emergency care. Patients should not independently discontinue or adjust prescribed antiseizure medication or undertake restrictive therapeutic diets without appropriate medical guidance.

A first recognized seizure, a convulsive seizure reaching approximately five minutes, repeated seizures without recovery, significant injury, breathing difficulty, or other serious symptoms require urgent medical assessment. The emergency medical number in Viet Nam is 115. General first aid information does not replace an individualized seizure action plan or professional emergency care.

Any illustrative patient situations are hypothetical and do not represent actual VLMA clinical activities or identifiable patients.